Hiten Patel (@HitenDPatel) header
Hiten Patel (@HitenDPatel) profile picture

Hiten Patel

@HitenDPatel

Urologic Oncologist @NM_Urology & @ChicagoVAMC @WUSTL, @HopkinsMedicine, @JohnsHopkinsSPH, @brady_urology, @LoyolaUrology @UroOnc Views are my own. #BLM

 Chicago, IL
feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=56321
Joined July 2012
  • Tweets736
  • Following706
  • Followers1.1K
61Media
Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)Photo by Hiten Patel (@HitenDPatel)
Hiten Patel retweeted
Tony Su (@ztonysu) profile picture
Tony Su@ztonysuOct 20
Thx to @JAMANetworkOpen for publishing our cost-effectiveness study of periop EV-pembro for cisplatin-ineligible MIBC @MaxKates @SBoorjian @tbivala1 @m_e_nielsen @siadaneshmand @SHPatelMD1 @nirmishsingla @JCensits @akfsurgeon @Sood11 @HitenDPatel @RuchikaTalwarMD @brady_urology
JAMA Network Open (@JAMANetworkOpen) profile pictureJAMA Network Open@JAMANetworkOpenOct 20
For cisplatin-ineligible muscle-invasive #BladderCancer, perioperative #EnfortumabVedotin plus pembrolizumab with radical cystectomy was associated with improved survival and was cost-effective vs radical cystectomy alone over 10 years. ja.ma/4seltqJ
Line graph showing the probability of being the preferred strategy versus the willingness-to-pay threshold in thousands of dollars per QALY. The intervention curve rises, while the control curve declines, intersecting near 100 thousand.

ALT Line graph showing the probability of being the preferred strategy versus the willingness-to-pay threshold in thousands of dollars per QALY. The intervention curve rises, while the control curve declines, intersecting near 100 thousand.

2
7
1
24
3,218
1/5: I am excited to share that VA STARPORT completed recruitment on Friday October 2, 2026. I am thankful to the Veterans who participated in the study and to our investigators and research teams across the VA who put in an incredible amount of work to get us here. @VAResearch
Image from Abhishek A. Solanki, MD MS (@abhiAsolanki)
7
16
3
62
6,224
The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most. For 33 years, PCF has brought science and lived experience together to move research forward. #PCFRetreat26
Image from Prostate Cancer Foundation (@PCFnews)
3
20
1
55
2,654
Hiten Patel retweeted
Andrew Gabrielson (@urogabe) profile picture
Andrew Gabrielson
@urogabeSep 22
Oral boards prep hasn't appreciably changed in decades, so I built MockUro, an AI examiner that walks you through ~250 canonical urology cases in Socratic Q&A format, grades your free-form answers across key domains, and adapts your study plan to your weak spots 🧵
11
19
1
104
18,292
Hiten Patel retweeted
Matt Cooperberg (@dr_coops) profile picture
Matt Cooperberg
@dr_coopsJun 2
And just like that, an era ended. Neoadj chemo before cystectomy is now a historical footnote #ev304 #keynoteb15 #ASCO26
QianJanieQin (@QianJanieQin) profile pictureQianJanieQin@QianJanieQinFeb 27
PRACTICE CHANGING: #KEYNOTEB15/EV304- in #MIBC, periop EV/P led to sig EFS (NR v 48.5m, 24m EFS 79.4 v 66.2%, HR0.53; 0.41-0.7), OS (NR v NR, 24m estimated OS 86.9 v 81.3%, HR 0.65; 0.48-0.89), pCR  (55.8 v 32.5%) benefit v. neoadj gem/cis, supporting EV/P as SOC in this setting
Image from QianJanieQin (@QianJanieQin)
Image from QianJanieQin (@QianJanieQin)
Image from QianJanieQin (@QianJanieQin)
Image from QianJanieQin (@QianJanieQin)
4
7
1
35
10,631
Replying to @NCSAUA
@NCSAUA Board Member Dr. James Brown and the section's Early Career Investigators Showcase nominees @Dr_i_pp_olito and @HitenDPatel selected for presentation at #AUA26.
Image from Amer. Urol. Assn. (@AmerUrological)
Image from Amer. Urol. Assn. (@AmerUrological)
4
1
7
447
Hiten Patel retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJMMay 12
New in our partnership with @DGlaucomflecken: the KEYNOTE-905 trial evaluated enfortumab vedotin plus pembrolizumab as perioperative therapy in patients with muscle-invasive bladder cancer who were ineligible to receive cisplatin. Read the full study for free: nej.md/DrG40
9
97
17
421
104,793
Hiten Patel retweeted
NM Urology (@NM_Urology) profile picture
NM Urology
@NM_UrologyMay 11
#AUA26 is just 4 days away! @NorthwesternMed Urology will be strongly represented at this year’s Annual Meeting by our faculty, residents, fellows, and medical students. We’re excited to share our work—and to connect with colleagues from around the world. Meet our representatives and follow along for conference updates!
Image from NM Urology (@NM_Urology)
4
11
1,663
Hiten Patel retweeted
Kari Tikkinen (@KariTikkinen) profile picture
Kari Tikkinen@KariTikkinenApr 22
🔥 POISE-3 Urology published in European Urology 🚨 In the largest randomized placebo-controlled #urology analysis of #TranexamicAcid (TXA), #TXA reduced major #bleeding risk by 37% (from 9.5% to 6.1%) with no clear increase in #thrombosis More at sciencedirect.com/science/ar… #EBM
Image from Kari Tikkinen (@KariTikkinen)
Image from Kari Tikkinen (@KariTikkinen)
Image from Kari Tikkinen (@KariTikkinen)
Image from Kari Tikkinen (@KariTikkinen)
2
40
3
129
21,317
Hiten Patel retweeted
NM Urology (@NM_Urology) profile picture
NM Urology
@NM_UrologyApr 8
🚨 PUBLICATION ALERT 🚨 Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications Authors included: Ashley Ross, MD, PhD, Edward Schaeffer, MD, PhD (@EdwardSchaeffer), Hiten Patel, MD (@HitenDPatel), Jamie Michael, MD, Nicole Handa, MD Publication link: nature.com/articles/s41698-0…
Image from NM Urology (@NM_Urology)
2
4
670
Hiten Patel retweeted
Scott Eggener (@uroegg) profile picture
Scott Eggener@uroeggApr 1
For those of us who still do some laparotomies. Small vs Large Bites for Abdominal Midline Incisions jamanetwork.com/journals/jam…
6
23
99
12,441
ARE WE WITNESSING THE BEST INDIVIDUAL PERFORMANCE EVER IN THE POSTSEASON ⁉️ 🧊 3 HR 🧊 6 scoreless IP 🧊 10 Ks SHOHEI OHTANI IS REALLY HIM 🐐
Image from Yahoo Sports (@YahooSports)
59
541
29
4,508
132,726
The hardest lessons after training aren’t always in the OR or clinic. 🙏 I wrote this essay for anyone navigating their first year as an attending. “Unseen Scars” in @JAMA_current 🔗jamanetwork.com/journals/jam…
Image from Adam B. Weiner, MD (@Adam_Weiner535)
55
160
33
704
103,425
Hiten Patel retweeted
NM Urology (@NM_Urology) profile picture
NM Urology
@NM_Urology29 Aug 2025
The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary, watch as we honor pioneers in the field and reflect on just some of the achievements that exemplify our dedication to better urology. #NMBetter
1
12
46
3,062
📰New in @UrolOncol! 💡Highlights: 1⃣Presence of EPE on MRI predicted prostatectomy outcomes 2⃣Combined biopsy showed the highest rate of grade concordance with prostatectomy 3⃣Our model for adverse surgical pat did not outperform existing nomograms 🔗bit.ly/4kGCuoS
Image from Urologic Oncology (@UrolOncol)
1
5
18
1,388
Hiten Patel retweeted
NEJM (@NEJM) profile picture
NEJM
@NEJM1 Jun 2025
Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: nej.md/4mh5RPL @ASCO
Image from NEJM (@NEJM)
18
354
82
807
220,351
Hiten Patel retweeted
Perry Xu (@perryjxu) profile picture
Perry Xu@perryjxu28 Apr 2025
Congratulations to our hardworking residents for winning 🥇at the National residents abstract Olympics!! @HitenDPatel @evan_panken @Jamie_A_Michael @c_arruzafrau @NM_Urology @NellieB_Uro @EdwardSchaeffer
Image from Perry Xu (@perryjxu)
Image from Perry Xu (@perryjxu)
1
5
24
1,718
Hiten Patel retweeted
NM Urology (@NM_Urology) profile picture
NM Urology
@NM_Urology20 Feb 2025
🚨PUBLICATION ALERT🚨 MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancer Authors included: @HitenDPatel, MD Article Link: pubmed.ncbi.nlm.nih.gov/3889…
Image from NM Urology (@NM_Urology)
1
11
1,183
Hiten Patel retweeted
NM Urology (@NM_Urology) profile picture
NM Urology
@NM_Urology11 Feb 2025
🚨PUBLICATION ALERT🚨 Utility of 18F-DCFPyL PET for local staging for high or very high-risk prostate cancer for patients undergoing radical prostatectomy Authors included: @EricLiUro, MD, @EdwardSchaeffer, MD, PhD, @HitenDPatel, MD, MPH, @ashleyrossmdphd, MD, PhD Article Link: bit.ly/410kzkC
Image from NM Urology (@NM_Urology)
Image from NM Urology (@NM_Urology)
Image from NM Urology (@NM_Urology)
Image from NM Urology (@NM_Urology)
1
3
17
2,215
Hiten Patel retweeted
NM Urology (@NM_Urology) profile picture
NM Urology
@NM_Urology5 Feb 2025
The 2024 Year in Review for Northwestern Medicine Urology is now available online. We proudly highlight significant research discoveries and clinical advances that have the potential to reshape the landscape of urology. This year has been marked by the development of therapies to treat urologic cancers, and breakthrough innovations in biopsy techniques that reduce patient risks. Celebrate these transformative insights and achievements from the past year below. breakthroughsforphysicians.n…
Image from NM Urology (@NM_Urology)
1
7
1
25
5,717
Load more